Real-world evidence supporting Tandem Control-IQ hybrid closed-loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations
Dr Alison Cave, MHRA chief safety officer, said that new medicines, such as tirzepatide, are more intensively monitored to ensure any new safety issues are identified promptly
Research weve presented this year suggests that 59% of people who reduce their dose slowly while building healthy habits maintain their weight loss six months later 1
"[A study] found that drinking 500 mL or about 17 ounces of water increased metabolic rate by approximately 30% in healthy men and women," Susie says
Ive gone UP, and DOWN, and usually back up again
Yet, with ipamorelin therapy, many patients see improvements